Prognosis

Concerns Rise Over Safety of Lab-Grown Blood Vessel

The Food and Drug Administration office in White Oak, Maryland. 

Photographer: Sarah Silbiger/Getty Images
Lock
This article is for subscribers only.

Hi, it’s Anna in Virginia. A month ago I wrote about a whistleblower who said FDA staff were pressured to approve a medical device. This wasn’t the end of the story, but before we get to that ...

Symvess, a Humacyte product, was approved by the Food and Drug Administration in December to help save limbs after severe trauma, whether it’s on the battlefield or in hospitals around the US.